Browse By Viral Diseases
This page shows data for Measles disease.
Total
Entries Retrieved: 5
| ID | Vaccine Name | Disease Name | Disease Classification | Virus Name | Nucleic Acid Content | Vaccine Type | Vaccine Status | Manufacturer | Year of Manufacturing | Manufacturing Country | Age | Dosage | Administration Route | Adjuvant | Target Strain | Description | Approving Organisation | Collaborating Organisation | Other Countries | Trade Name | PMID | Clinical Trial ID | Reference Link | Additional Links |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10308 | MVA-mBN85B | Measles | Exanthous | Morbillivirus | negative-sense, single-stranded RNA | Recombinant viral vector | Phase 2 | Bavarian Nordic | 2012 | South Africa | 6 months - 6 years | 2 doses 4 weeks apart | Subcutaneous | NA | Attenuated Modified Vaccinia Virus Ankara, strain encoding hemagglutinin protein, fusion protein and nucleoprotein of measles virus | NA | NA | NA | NA | Rouvax | NA | NCT00891007 | https://clinicaltrials.gov/ct2/show/NCT00891007?recrs=abde&cond=measles+vaccines&phase=123&draw=2&rank=3 | NA |